{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:19:10Z","timestamp":1792163950278,"version":"4.4.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,11,17]],"date-time":"2009-11-17T00:00:00Z","timestamp":1258416000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,11,17]],"date-time":"2009-11-17T00:00:00Z","timestamp":1258416000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1038\/mp.2009.116","type":"journal-article","created":{"date-parts":[[2009,11,17]],"date-time":"2009-11-17T04:02:16Z","timestamp":1258430536000},"page":"393-403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":566,"title":["CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-\u03b1: relationship to CNS immune responses and depression"],"prefix":"10.1038","volume":"15","author":[{"given":"C L","family":"Raison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Dantzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K W","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B J","family":"Woolwine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J R","family":"Spivey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A H","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,17]]},"reference":[{"key":"BFmp2009116_CR1","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O\u2019Connor JC, Freund GG, Johnson RW, Kelley KW . From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9: 46\u201356.","journal-title":"Nat Rev Neurosci"},{"key":"BFmp2009116_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/PSY.0b013e318190d7de","volume":"71","author":"GE Miller","year":"2009","unstructured":"Miller GE, Rohleder N, Cole SW . Chronic interpersonal stress predicts activation of pro- and anti-inflammatory signaling pathways 6 months later. Psychosom Med 2009; 71: 57\u201362.","journal-title":"Psychosom Med"},{"key":"BFmp2009116_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2008.01.004","volume":"85","author":"H Anisman","year":"2008","unstructured":"Anisman H, Merali Z, Hayley S . Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Prog Neurobiol 2008; 85: 1\u201374.","journal-title":"Prog Neurobiol"},{"key":"BFmp2009116_CR4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0006-8993(95)01415-2","volume":"711","author":"R Yirmiya","year":"1996","unstructured":"Yirmiya R . Endotoxin produces a depressive-like episode in rats. Brain Res 1996; 711: 163\u2013174.","journal-title":"Brain Res"},{"key":"BFmp2009116_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1006\/brbi.2000.0597","volume":"15","author":"EP Zorrilla","year":"2001","unstructured":"Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 2001; 15: 199\u2013226.","journal-title":"Brain Behav Immun"},{"key":"BFmp2009116_CR6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/archpsyc.58.5.445","volume":"58","author":"A Reichenberg","year":"2001","unstructured":"Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A et al. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 2001; 58: 445\u2013452.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp2009116_CR7","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.biopsych.2007.12.007","volume":"63","author":"L Brydon","year":"2008","unstructured":"Brydon L, Harrison NA, Walker C, Steptoe A, Critchley HD . Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biol Psychiatry 2008; 63: 1022\u20131029.","journal-title":"Biol Psychiatry"},{"key":"BFmp2009116_CR8","unstructured":"Capuron L, Fornwalt FB, Knight BT, Harvey PD, Ninan PT, Miller AH . Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?. J Affect Disord (in press)."},{"key":"BFmp2009116_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(05)67763-X","volume":"367","author":"S Tyring","year":"2006","unstructured":"Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 2006; 367: 29\u201335.","journal-title":"Lancet"},{"key":"BFmp2009116_CR10","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/sj.mp.4001805","volume":"11","author":"N Muller","year":"2006","unstructured":"Muller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Muller B et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 2006; 11: 680\u2013684.","journal-title":"Mol Psychiatry"},{"key":"BFmp2009116_CR11","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2009","unstructured":"Miller AH, Maletic V, Raison CL . Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009; 65: 732\u2013741.","journal-title":"Biol Psychiatry"},{"key":"BFmp2009116_CR12","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.biopsych.2007.05.026","volume":"62","author":"JC Felger","year":"2007","unstructured":"Felger JC, Alagbe O, Hu F, Mook D, Freeman AA, Sanchez MM et al. Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression. Biol Psychiatry 2007; 62: 1324\u20131333.","journal-title":"Biol Psychiatry"},{"key":"BFmp2009116_CR13","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.biopsych.2008.08.010","volume":"65","author":"CL Raison","year":"2009","unstructured":"Raison CL, Borisov AS, Majer M, Drake DF, Pagnoni G, Woolwine BJ et al. Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biol Psychiatry 2009; 65: 296\u2013303.","journal-title":"Biol Psychiatry"},{"key":"BFmp2009116_CR14","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.bbi.2007.05.005","volume":"21","author":"N Quan","year":"2007","unstructured":"Quan N, Banks WA . Brain-immune communication pathways. Brain Behav Immun 2007; 21: 727\u2013735.","journal-title":"Brain Behav Immun"},{"key":"BFmp2009116_CR15","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1523\/JNEUROSCI.3567-08.2009","volume":"29","author":"C D\u2019Mello","year":"2009","unstructured":"D\u2019Mello C, Le T, Swain MG . Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factor alpha signaling during peripheral organ inflammation. J Neurosci 2009; 29: 2089\u20132102.","journal-title":"J Neurosci"},{"key":"BFmp2009116_CR16","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1159\/000097295","volume":"3","author":"J Weidenfeld","year":"1996","unstructured":"Weidenfeld J, Yirmiya R . Effects of bacterial endotoxin on the glucocorticoid feedback regulation of adrenocortical response to stress. Neuroimmunomodulation 1996; 3: 352\u2013357.","journal-title":"Neuroimmunomodulation"},{"key":"BFmp2009116_CR17","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1176\/appi.ajp.160.7.1342","volume":"160","author":"L Capuron","year":"2003","unstructured":"Capuron L, Raison CL, Musselman DL, Lawson DH, Nemeroff CB, Miller AH . Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am J Psychiatry 2003; 160: 1342\u20131345.","journal-title":"Am J Psychiatry"},{"key":"BFmp2009116_CR18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1089\/107999003322277829","volume":"23","author":"CM Robinson","year":"2003","unstructured":"Robinson CM, Shirey KA, Carlin JM . Synergistic transcriptional activation of indoleamine dioxygenase by IFN-gamma and tumor necrosis factor-alpha. J Interferon Cytokine Res 2003; 23: 413\u2013421.","journal-title":"J Interferon Cytokine Res"},{"key":"BFmp2009116_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cyto.2006.07.007","volume":"35","author":"CM Robinson","year":"2006","unstructured":"Robinson CM, Hale PT, Carlin JM . NF-kappa B activation contributes to indoleamine dioxygenase transcriptional synergy induced by IFN-gamma and tumor necrosis factor-alpha. Cytokine 2006; 35: 53\u201361.","journal-title":"Cytokine"},{"key":"BFmp2009116_CR20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1089\/jir.1997.17.589","volume":"17","author":"LA Pemberton","year":"1997","unstructured":"Pemberton LA, Kerr SJ, Smythe G, Brew BJ . Quinolinic acid production by macrophages stimulated with IFN-gamma, TNF-alpha, and IFN-alpha. J Interferon Cytokine Res 1997; 17: 589\u2013595.","journal-title":"J Interferon Cytokine Res"},{"key":"BFmp2009116_CR21","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/jb\/mvj072","volume":"139","author":"H Fujigaki","year":"2006","unstructured":"Fujigaki H, Saito K, Fujigaki S, Takemura M, Sudo K, Ishiguro H et al. The signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 are not essential for the induction of indoleamine 2,3-dioxygenase by lipopolysaccharide: involvement of p38 mitogen-activated protein kinase and nuclear factor-kappaB pathways, and synergistic effect of several proinflammatory cytokines. J Biochem 2006; 139: 655\u2013662.","journal-title":"J Biochem"},{"key":"BFmp2009116_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-1-4615-0135-0_3","volume":"527","author":"AL Mellor","year":"2003","unstructured":"Mellor AL, Munn D, Chandler P, Keskin D, Johnson T, Marshall B et al. Tryptophan catabolism and T cell responses. Adv Exp Med Biol 2003; 527: 27\u201335.","journal-title":"Adv Exp Med Biol"},{"key":"BFmp2009116_CR23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/clinchem\/40.2.288","volume":"40","author":"MJ Owens","year":"1994","unstructured":"Owens MJ, Nemeroff CB . Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 1994; 40: 288\u2013295.","journal-title":"Clin Chem"},{"key":"BFmp2009116_CR24","first-page":"717","volume-title":"Textbook of Psychopharmacology","author":"BH Flores","year":"2004","unstructured":"Flores BH, Musselman DL, DeBattista C, Garlow SJ, Schatzberg AF, Nemeroff CB . Biology of mood disorders. In: Schatzberg AF, Nemeroff CB (eds). Textbook of Psychopharmacology, 3rd edn. America Psychiatric Publishing, Inc.: Washington, DC, 2004, pp 717\u2013763."},{"key":"BFmp2009116_CR25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/sj.mp.4002148","volume":"14","author":"JC O\u2019Connor","year":"2009","unstructured":"O\u2019Connor JC, Lawson MA, Andre C, Moreau M, Lestage J, Castanon N et al. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 2009; 14: 511\u2013522.","journal-title":"Mol Psychiatry"},{"key":"BFmp2009116_CR26","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.4049\/jimmunol.0802722","volume":"182","author":"JC O\u2019Connor","year":"2009","unstructured":"O\u2019Connor JC, Lawson MA, Andre C, Briley EM, Szegedi SS, Lestage J et al. Induction of IDO by bacille Calmette-Guerin is responsible for development of murine depressive-like behavior. J Immunol 2009; 182: 3202\u20133212.","journal-title":"J Immunol"},{"key":"BFmp2009116_CR27","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/sj.mp.4000872","volume":"6","author":"M Maes","year":"2001","unstructured":"Maes M, Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M et al. Treatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activation. Mol Psychiatry 2001; 6: 475\u2013480.","journal-title":"Mol Psychiatry"},{"key":"BFmp2009116_CR28","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/sj.mp.4000995","volume":"7","author":"L Capuron","year":"2002","unstructured":"Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, Dantzer R . Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry 2002; 7: 468\u2013473.","journal-title":"Mol Psychiatry"},{"key":"BFmp2009116_CR29","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0006-3223(03)00173-2","volume":"54","author":"L Capuron","year":"2003","unstructured":"Capuron L, Neurauter G, Musselman DL, Lawson DH, Nemeroff CB, Fuchs D et al. Interferon-alpha-induced changes in tryptophan metabolism. Relationship to depression and paroxetine treatment. Biol Psychiatry 2003; 54: 906\u2013914.","journal-title":"Biol Psychiatry"},{"key":"BFmp2009116_CR30","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/sj.mp.4001600","volume":"10","author":"MC Wichers","year":"2005","unstructured":"Wichers MC, Koek GH, Robaeys G, Verkerk R, Scharpe S, Maes M . IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Mol Psychiatry 2005; 10: 538\u2013544.","journal-title":"Mol Psychiatry"},{"key":"BFmp2009116_CR31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/00004714-200202000-00014","volume":"22","author":"S Bonaccorso","year":"2002","unstructured":"Bonaccorso S, Marino V, Puzella A, Pasquini M, Biondi M, Artini M et al. Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. J Clin Psychopharmacol 2002; 22: 86\u201390.","journal-title":"J Clin Psychopharmacol"},{"key":"BFmp2009116_CR32","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00432-007-0191-3","volume":"133","author":"K Schroecksnadel","year":"2007","unstructured":"Schroecksnadel K, Fiegl M, Prassl K, Winkler C, Denz HA, Fuchs D . Diminished quality of life in patients with cancer correlates with tryptophan degradation. J Cancer Res Clin Oncol 2007; 133: 477\u2013485.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFmp2009116_CR33","first-page":"873","volume":"3","author":"D Fuchs","year":"1990","unstructured":"Fuchs D, Moller AA, Reibnegger G, Stockle E, Werner ER, Wachter H . Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic\/psychiatric symptoms. J Acquir Immune Defic Syndr 1990; 3: 873\u2013876.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"BFmp2009116_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0091-3057(90)90043-H","volume":"37","author":"L Vecsei","year":"1990","unstructured":"Vecsei L, Beal MF . Influence of kynurenine treatment on open-field activity, elevated plus-maze, avoidance behaviors and seizures in rats. Pharmacol Biochem Behav 1990; 37: 71\u201376.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFmp2009116_CR35","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/S0889-1591(02)00006-5","volume":"16","author":"B Widner","year":"2002","unstructured":"Widner B, Laich A, Sperner-Unterweger B, Ledochowski M, Fuchs D . Neopterin production, tryptophan degradation, and mental depression\u2014what is the link? Brain Behav Immun 2002; 16: 590\u2013595.","journal-title":"Brain Behav Immun"},{"key":"BFmp2009116_CR36","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/sj.mp.4002006","volume":"12","author":"N Muller","year":"2007","unstructured":"Muller N, Schwarz MJ . The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry 2007; 12: 988\u20131000.","journal-title":"Mol Psychiatry"},{"key":"BFmp2009116_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.102.034439","volume":"303","author":"R Schwarcz","year":"2002","unstructured":"Schwarcz R, Pellicciari R . Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther 2002; 303: 1\u201310.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFmp2009116_CR38","doi-asserted-by":"crossref","first-page":"15496","DOI":"10.1016\/S0021-9258(18)82284-0","volume":"268","author":"K Saito","year":"1993","unstructured":"Saito K, Crowley JS, Markey SP, Heyes MP . A mechanism for increased quinolinic acid formation following acute systemic immune stimulation. J Biol Chem 1993; 268: 15496\u201315503.","journal-title":"J Biol Chem"},{"key":"BFmp2009116_CR39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/glia.20090","volume":"49","author":"GJ Guillemin","year":"2005","unstructured":"Guillemin GJ, Smythe G, Takikawa O, Brew BJ . Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia 2005; 49: 15\u201323.","journal-title":"Glia"},{"key":"BFmp2009116_CR40","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4615-0135-0_12","volume":"527","author":"GJ Guillemin","year":"2003","unstructured":"Guillemin GJ, Smith DG, Smythe GA, Armati PJ, Brew BJ . Expression of the kynurenine pathway enzymes in human microglia and macrophages. Adv Exp Med Biol 2003; 527: 105\u2013112.","journal-title":"Adv Exp Med Biol"},{"key":"BFmp2009116_CR41","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/BF00966592","volume":"16","author":"C Rios","year":"1991","unstructured":"Rios C, Santamaria A . Quinolinic acid is a potent lipid peroxidant in rat brain homogenates. Neurochem Res 1991; 16: 1139\u20131143.","journal-title":"Neurochem Res"},{"key":"BFmp2009116_CR42","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1742-2094-2-16","volume":"2","author":"GJ Guillemin","year":"2005","unstructured":"Guillemin GJ, Wang L, Brew BJ . Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex. J Neuroinflammation 2005; 2: 16.","journal-title":"J Neuroinflammation"},{"key":"BFmp2009116_CR43","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1365-2990.2005.00655.x","volume":"31","author":"GJ Guillemin","year":"2005","unstructured":"Guillemin GJ, Brew BJ, Noonan CE, Takikawa O, Cullen KM . Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus. Neuropathol Appl Neurobiol 2005; 31: 395\u2013404.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"BFmp2009116_CR44","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000089622","volume":"2","author":"GJ Guillemin","year":"2005","unstructured":"Guillemin GJ, Meininger V, Brew BJ . Implications for the kynurenine pathway and quinolinic acid in amyotrophic lateral sclerosis. Neurodegener Dis 2005; 2: 166\u2013176.","journal-title":"Neurodegener Dis"},{"key":"BFmp2009116_CR45","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/978-1-4615-0135-0_16","volume":"527","author":"P Guidetti","year":"2003","unstructured":"Guidetti P, Schwarcz R . 3-Hydroxykynurenine and quinolinate: pathogenic synergism in early grade Huntington's disease? Adv Exp Med Biol 2003; 527: 137\u2013145.","journal-title":"Adv Exp Med Biol"},{"issue":"Pt 5","key":"BFmp2009116_CR46","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1093\/brain\/115.5.1249","volume":"115","author":"MP Heyes","year":"1992","unstructured":"Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 1992; 115 (Pt 5): 1249\u20131273.","journal-title":"Brain"},{"key":"BFmp2009116_CR47","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1017\/S1092852900016734","volume":"13","author":"L McNally","year":"2008","unstructured":"McNally L, Bhagwagar Z, Hannestad J . Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr 2008; 13: 501\u2013510.","journal-title":"CNS Spectr"},{"key":"BFmp2009116_CR48","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.biopsych.2004.02.009","volume":"56","author":"L Capuron","year":"2004","unstructured":"Capuron L, Miller AH . Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry 2004; 56: 819\u2013824.","journal-title":"Biol Psychiatry"},{"key":"BFmp2009116_CR49","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4088\/JCP.v66n0106","volume":"66","author":"CL Raison","year":"2005","unstructured":"Raison CL, Borisov AS, Broadwell SD, Capuron L, Woolwine BJ, Jacobson IM et al. Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. J Clin Psychiatry 2005; 66: 41\u201348.","journal-title":"J Clin Psychiatry"},{"key":"BFmp2009116_CR50","volume-title":"Structured Clinical Interview for DSM-IV","author":"MB First","year":"1997","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JB . Structured Clinical Interview for DSM-IV. American Psychiatric Press: Washington, DC, 1997."},{"key":"BFmp2009116_CR51","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1001\/archpsyc.1983.01790060110016","volume":"40","author":"MF Folstein","year":"1983","unstructured":"Folstein MF, Robins LN, Helzer JE . The mini-mental state examination. Arch Gen Psychiatry 1983; 40: 812.","journal-title":"Arch Gen Psychiatry"},{"key":"BFmp2009116_CR52","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.bbi.2007.12.009","volume":"22","author":"M Majer","year":"2008","unstructured":"Majer M, Welberg LA, Capuron L, Pagnoni G, Raison CL, Miller AH . IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C. Brain Behav Immun 2008; 22: 870\u2013880.","journal-title":"Brain Behav Immun"},{"key":"BFmp2009116_CR53","unstructured":"Raison CL, Borisov AS, Woolwine BJ, Massung B, Vogt G, Miller AH . Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior. Mol Psychiatry (in press)."},{"key":"BFmp2009116_CR54","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M . A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382\u2013389.","journal-title":"Br J Psychiatry"},{"key":"BFmp2009116_CR55","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"JD Cohen","year":"1988","unstructured":"Cohen JD . Statistical Power Analysis for the Behavioral Sciences, 2nd edn. Lawrence Erlbaum Associates: Hillsdale, NJ, 1988."},{"key":"BFmp2009116_CR56","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1111\/j.1471-4159.1991.tb03460.x","volume":"56","author":"S Fukui","year":"1991","unstructured":"Fukui S, Schwarcz R, Rapoport SI, Takada Y, Smith QR . Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J Neurochem 1991; 56: 2007\u20132017.","journal-title":"J Neurochem"},{"key":"BFmp2009116_CR57","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1471-4159.2004.02708.x","volume":"91","author":"LM Borland","year":"2004","unstructured":"Borland LM, Michael AC . Voltammetric study of the control of striatal dopamine release by glutamate. J Neurochem 2004; 91: 220\u2013229.","journal-title":"J Neurochem"},{"key":"BFmp2009116_CR58","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00702-006-0562-y","volume":"114","author":"HQ Wu","year":"2007","unstructured":"Wu HQ, Rassoulpour A, Schwarcz R . Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain? J Neural Transm 2007; 114: 33\u201341.","journal-title":"J Neural Transm"},{"key":"BFmp2009116_CR59","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S0006-8993(96)01371-6","volume":"747","author":"H Shuto","year":"1997","unstructured":"Shuto H, Kataoka Y, Horikawa T, Fujihara N, Oishi R . Repeated interferon-alpha administration inhibits dopaminergic neural activity in the mouse brain. Brain Res 1997; 747: 348\u2013351.","journal-title":"Brain Res"},{"issue":"Pt 6","key":"BFmp2009116_CR60","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1093\/brain\/116.6.1425","volume":"116","author":"MP Heyes","year":"1993","unstructured":"Heyes MP, Saito K, Major EO, Milstien S, Markey SP, Vickers JH . A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. Brain 1993; 116 (Pt 6): 1425\u20131450.","journal-title":"Brain"},{"key":"BFmp2009116_CR61","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/glia.10175","volume":"41","author":"GJ Guillemin","year":"2003","unstructured":"Guillemin GJ, Croitoru-Lamoury J, Dormont D, Armati PJ, Brew BJ . Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes. Glia 2003; 41: 371\u2013381.","journal-title":"Glia"},{"key":"BFmp2009116_CR62","doi-asserted-by":"crossref","first-page":"6896","DOI":"10.4049\/jimmunol.161.12.6896","volume":"161","author":"JM Weiss","year":"1998","unstructured":"Weiss JM, Downie SA, Lyman WD, Berman JW . Astrocyte-derived monocyte-chemoattractant protein-1 directs the transmigration of leukocytes across a model of the human blood-brain barrier. J Immunol 1998; 161: 6896\u20136903.","journal-title":"J Immunol"},{"key":"BFmp2009116_CR63","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1111\/j.1471-4159.2008.05241.x","volume":"105","author":"R Owe-Young","year":"2008","unstructured":"Owe-Young R, Webster NL, Mukhtar M, Pomerantz RJ, Smythe G, Walker D et al. Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity. J Neurochem 2008; 105: 1346\u20131357.","journal-title":"J Neurochem"},{"key":"BFmp2009116_CR64","first-page":"167","volume":"1","author":"DA Scrandis","year":"2008","unstructured":"Scrandis DA, Langenberg P, Tonelli LH, Sheikh TM, Manogura AC, Alberico LA et al. Prepartum depressive symptoms correlate positively with C-reactive protein levels and negatively with tryptophan levels: a preliminary report. Int J Child Health Hum Dev 2008; 1: 167\u2013174.","journal-title":"Int J Child Health Hum Dev"},{"key":"BFmp2009116_CR65","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jad.2004.12.013","volume":"86","author":"C Kohl","year":"2005","unstructured":"Kohl C, Walch T, Huber R, Kemmler G, Neurauter G, Fuchs D et al. Measurement of tryptophan, kynurenine and neopterin in women with and without postpartum blues. J Affect Disord 2005; 86: 135\u2013142.","journal-title":"J Affect Disord"},{"key":"BFmp2009116_CR66","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/S0024-3205(02)01853-2","volume":"71","author":"M Maes","year":"2002","unstructured":"Maes M, Verkerk R, Bonaccorso S, Ombelet W, Bosmans E, Scharpe S . Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation. Life Sci 2002; 71: 1837\u20131848.","journal-title":"Life Sci"},{"key":"BFmp2009116_CR67","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/0006-3223(94)91189-4","volume":"36","author":"AB Orlikov","year":"1994","unstructured":"Orlikov AB, Prakhye IB, Ryzov IV . Kynurenine in blood plasma and DST in patients with endogenous anxiety and endogenous depression. Biol Psychiatry 1994; 36: 97\u2013102.","journal-title":"Biol Psychiatry"},{"key":"BFmp2009116_CR68","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/BF00430761","volume":"76","author":"SE Moller","year":"1982","unstructured":"Moller SE, Kirk L, Honore P . Tryptophan tolerance and metabolism in endogenous depression. Psychopharmacology (Berl) 1982; 76: 79\u201383.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFmp2009116_CR69","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/BF00426632","volume":"59","author":"K Wood","year":"1978","unstructured":"Wood K, Harwood J, Coppen A . The effect of antidepressant drugs on plasma kynurenine in depressed patients. Psychopharmacology (Berl) 1978; 59: 263\u2013266.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFmp2009116_CR70","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","volume":"98","author":"AM Myint","year":"2007","unstructured":"Myint AM, Kim YK, Verkerk R, Scharpe S, Steinbusch H, Leonard B . Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord 2007; 98: 143\u2013151.","journal-title":"J Affect Disord"},{"key":"BFmp2009116_CR71","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0893-133X(01)00407-9","volume":"26","author":"L Capuron","year":"2002","unstructured":"Capuron L, Gumnick JF, Musselman DL, Lawson DH, Reemsnyder A, Nemeroff CB et al. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 2002; 26: 643\u2013652.","journal-title":"Neuropsychopharmacology"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/mp2009116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2009116","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/mp2009116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T11:39:20Z","timestamp":1685187560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp2009116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,17]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["BFmp2009116"],"URL":"https:\/\/doi.org\/10.1038\/mp.2009.116","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,17]]},"assertion":[{"value":"30 April 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}